Corrinne Burns

Royal Pharmaceutical Society Correspondent

Corrinne Burns is Royal Pharmaceutical Society Correspondent at The Pharmaceutical Journal.

Antidepressant discontinuation does not cause severe symptoms in most people, study finds

Researchers found that patients who stopped antidepressants reported discontinuation symptoms that were below the threshold for clinical significance.…

Pharmacies to trial test for risk of oesophageal cancer

NHS England said that the “heartburn health check” could help transfer care from hospitals to the community, as part of the NHS ten-year health plan.…

National Pharmacy Board meeting: 19 June 2025

An overview of the latest open meetings of the national pharmacy boards.…

Warning over risk of Guillain-Barré syndrome following RSV vaccination

The Medicines and Healthcare products Regulatory Agency said that, as of 2 June 2025, it had received 21 Yellow Card reports of suspected Guillain-Barré syndrome in older adults aged 75–79 years after they received the Abrysvo vaccine.…

NHS ten-year plan should result in faster medicines access, says NICE

Under the ten-year health plan, the National Institute for Health and Care Excellence and Medicines and Healthcare products Regulatory Agency will work together to speed up medicines approvals.…

Support systems: how the Royal Pharmaceutical Society is investing in the future of safe prescribing

By combining financial support with trusted BNF content, the Royal Pharmaceutical Society is strengthening clinical decision-making through its partnership with Dosium.…

Community pharmacy awarded 4% global sum funding increase by Scottish government

Community Pharmacy Scotland said the increase will contribute to additional costs, “such as national insurance impacts”.…

Community pharmacist independent prescribers increased by one-third from 2023 to 2024, workforce survey shows

Despite the increase in qualified pharmacist independent prescribers, NHS England's survey reported regional variation in the number of them using their prescribing qualification in practice.…

Smoking cessation pill Champix returns to market four years after withdrawal over carcinogen

Manufacturer Pfizer said it had “taken steps to address the presence of nitrosamines in Champix, including lowering the levels to meet regulatory requirements”.…

Hospice UK calls for national standard in community pharmacy palliative care

The report has also identified opportunities to “strengthen education and training in palliative care and bereavement support for rural pharmacists”.…